MAPS Canada School of Psychedelics

Describe the goals and design of Therapsil’s new psilocybin-assisted psychotherapy clinical trial.

Differentiate stakeholder-funded clinical research from traditional industry-sponsored trials.

Assess the potential benefits and challenges associated with stakeholder-funded models in psychedelic research.

Identify key scientific considerations, including study methodology, safety protocols, and outcome measures.

Discuss the ethical questions raised by charging participants to join a clinical trial.

Understand the motivations behind launching a wellbeing-focused psychedelic trial at this time.

Evaluate how this model could shape the future of psychedelic research and access pathways in Canada.